查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561639

2024-2032 年按組件（3D 生物列印機、支架、生物材料）、應用（研究、臨床）、最終用戶（醫院、研究組織和學術機構、生物製藥公司）和地區分類的 3D 生物列印市場報告

3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球3D生物列印市場規模達12.058IMARC Group美元。不斷成長的老年人口、對研發 (R&D) 活動的日益關注以及市場干擾的減少是推動市場成長的一些關鍵因素。

3D生物列印市場分析：

  • 主要市場促進因素：3D生物列印在個人化醫療中的使用不斷增加，主要推動了市場的成長。 3D生物列印可以創建患者特定的組織和器官，從而實現個人化治療計劃並降低移植排斥的風險。
  • 主要市場趨勢：擴大利用生物列印來製造具有精確幾何形狀和生物功能的複雜生物醫學設備和植入物，是推動市場成長的重要趨勢之一。此外，3D生物列印技術的快速進步，包括改進的生物材料和列印技術，也有助於市場的擴張。
  • 競爭格局：全球市場上的一些領先參與者包括 3D Systems Inc.、Aspect Biosystems Ltd.、Cellink、Cyfuse Biomedical KK、EnvisionTEC GmbH (Desktop Metal Inc.)、GeSiM - Gesellschaftfur Silizium-Mikrosysteme mbH、Material Incise、 Organovo Holdings .、Poietis、RegenHU 和Stratasys Ltd. 等。
  • 地理格局：報告顯示，北美（美國和加拿大）是生物3D列印的最大市場。推動北美 3D 生物列印市場的一些因素包括各種慢性疾病的日益普及、主要參與者的廣泛存在以及私人和政府投資的增加。
  • 挑戰與機會：全球3D生物列印市場面臨成本高、技術複雜與監管障礙等挑戰。然而，它提供了透過創新的組織工程解決方案來推進個人化醫療、提高藥物測試準確性和解決器官移植短缺的機會。

3D生物列印市場趨勢：

加強藥物測試和開發

3D生物列印機對於藥物測試和臨床試驗應用非常重要。預計它們將大大減少動物試驗的需要，從而在倫理上有利且具有成本效益。隨著3D生物列印的出現，藥物開發商可以透過在類人3D列印組織上測試新藥，輕鬆識別與人體臨床試驗相關的併發症，從而減少後期失敗造成的損失。此外，公司不斷增加的研發投資進一步增加了對 3D 生物列印等創新技術的需求。例如，根據美國國會預算辦公室公佈的資料，2021年，全球製藥業在研發上的支出接近2,000億美元，而2019年為8,300萬美元。的研發投資為17.42 億美元，而2020 年為13.48 億美元。大量投資將在未來幾年推動3D 生物列印市場的規模。

技術進步

3D 生物列印技術的不斷進步進一步為整個市場提供了利潤豐厚的成長機會。此外，各個領先的市場參與者正在合作並建立夥伴關係，以開發更先進、更有效率的 3D 生物列印技術。例如，2024 年 6 月，先進的組織模擬技術公司 Ronawk 與 B9Creations 合作，利用 Ronawk 的 Bio-Blocks 開發並大量生產 3D 生物列印水凝膠。與迫使細胞進入人工環境的傳統方法不同，Ronawk 的生物塊重建了細胞自然形成組織的條件。這導致組織與人類和動物組織的天然結構和功能非常相似。同樣，2022 年 9 月，印度科學研究所 (IISc) 宣布與瑞典生物列印解決方案公司 CELLINK 合作，向卓越中心 (CoE) 提供兩到三台生物印表機，每台都使用不同的列印方式技術以自己的成本。此外，2022 年 12 月，CELLINK 和 IISc 在印度共同建立了班加羅爾開創性的 3D 生物列印卓越中心。 3D 生物列印領域的此類創新、合作和擴展預計將對預測期內的 3D 生物列印市場前景產生積極影響。

癌症研究中不斷成長的產品應用

3D生物列印廣泛用於創建逼真的腫瘤模型，這些模型密切模仿實際人類腫瘤的複雜性和微環境。這些生物列印模型使研究人員能夠在受控環境下研究癌症進展、轉移和腫瘤-基質相互作用。此外，全球癌症病例的不斷增加進一步為整個市場提供了利潤豐厚的成長機會。例如，國際癌症研究機構（IARC）估計，2020年約有1929萬名癌症病例。預計到 2030 年，這些病例將增加到 2,458 萬例。除此之外，肺癌和乳癌是個體中最常見的兩種癌症。加拿大癌症協會（CCS）表示，2020年，近29,800名加拿大人被診斷出罹患肺癌，佔所有新發癌症病例的13%。預計約有21,200 名加拿大人死於肺癌，佔2020 年所有癌症死亡人數的25%。藥物機制並個性化客製化治療方案。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球 3D 生物列印市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按組成部分

  • 3D生物列印機
    • 市場趨勢
    • 關鍵環節
      • 注射器/擠出生物列印
      • 噴墨生物列印
      • 磁浮生物列印
      • 雷射輔助生物列印
      • 其他
    • 市場預測
  • 鷹架
    • 市場趨勢
    • 市場預測
  • 生物材料
    • 市場趨勢
    • 關鍵環節
      • 活細胞
      • 水凝膠
      • 細胞外基質
      • 其他
    • 市場預測

第 7 章：市場區隔：按應用

  • 研究
    • 市場趨勢
    • 關鍵環節
      • 藥物研究
      • 再生醫學
      • 3D 細胞培養
    • 市場預測
  • 臨床
    • 市場趨勢
    • 關鍵環節
      • 皮膚
      • 骨骼和軟骨
      • 血管
      • 其他
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場趨勢
    • 市場預測
  • 研究機構及學術機構
    • 市場趨勢
    • 市場預測
  • 生物製藥公司
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3D Systems Inc.
    • Aspect Biosystems Ltd.
    • Cellink
    • Cyfuse Biomedical KK
    • EnvisionTEC GmbH (Desktop Metal Inc.)
    • GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
    • Materialise
    • Organovo Holdings Inc.
    • Poietis
    • RegenHU
    • Stratasys Ltd.
Product Code: SR112024A4556

The global 3D bioprinting market size reached US$ 1,205.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 4,281.9 Million by 2032, exhibiting a growth rate (CAGR) of 14.7% during 2024-2032. The growing geriatric population, increasing focus on research and development (R&D) activities, and less disrupted market represent some of the key factors driving the market growth.

3D Bioprinting Market Analysis:

  • Major Market Drivers: The increasing utilization of 3D bioprinting in personalized medicine is primarily driving the growth of the market. 3D bioprinting can create patient-specific tissues and organs, enabling personalized treatment plans and reducing the risk of transplant rejection.
  • Key Market Trends: The escalating utilization of bioprinting to manufacture complex biomedical devices and implants with precise geometries and biological functionalities is one of the significant trends driving the growth of the market. Furthermore, rapid advancements in 3D bioprinting technology, including improved biomaterials and printing techniques, are also contributing to the market expansion.
  • Competitive Landscape: Some of the leading players operating in the global market include 3D Systems Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU, and Stratasys Ltd., among others.
  • Geographical Landscape: According to the report, North America (the United States and Canada) was the largest market for 3D bioprinting. Some of the factors driving the North American 3D bioprinting market include the growing prevalence of various chronic diseases, the wide presence of key players, and increasing private and government investment.
  • Challenges and Opportunities: The global 3D bioprinting market faces challenges such as high costs, technical complexities, and regulatory hurdles. However, it presents opportunities to advance personalized medicine, improve drug testing accuracy, and address organ transplant shortages through innovative tissue engineering solutions.

3D Bioprinting Market Trends:

Increasing Drug Testing and Development

3D bioprinters are highly important for drug testing and clinical trial applications. They are expected to drastically reduce the need for animal trials, thus being ethically beneficial and cost-effective. With the advent of 3D bioprinting, drug developers can easily identify complications associated with human clinical trials by testing new drugs on human-like 3D-printed tissues, thereby reducing losses from late-stage failures. Additionally, the increasing investment in research and development by the companies is further escalating the demand for innovative technologies like 3D bioprinting. For instance, according to the data published by the Congressional Budget Office, in 2021, it has been observed that pharmaceutical industries spent nearly US$ 200 Billion on research and development in 2020 globally compared to US$ 83 Million in 2019. Similarly, Danaher Corporation invested US$ 1,742 Million in its research and development in 2021, as compared to US$ 1,348 Million in 2020. In addition, Bio-Rad Laboratories Inc. invested US$ 879.6 Million in 2021 as compared to US$ 800.3 Million in 2020. Such significant investments in drug trials and drug development are anticipated to propel the 3D bioprinting market size in the coming years.

Technological Advancements

Ongoing technological advancements in 3D bioprinting are further offering lucrative growth opportunities to the overall market. Additionally, various leading market players are collaborating and forming partnerships to develop more advanced and efficient 3D bioprinting technologies. For instance, in June 2024, advanced tissue mimetic technologies company Ronawk partnered with B9Creations to develop and mass-produce 3D bioprinted hydrogels leveraging Ronawk's Bio-Blocks. Unlike traditional methods that force cells into artificial environments, Ronawk's Bio-Blocks recreate conditions that allow cells to form tissues naturally. This results in tissue that closely resembles the native architecture and function of human and animal tissues. Similarly, in September 2022, the Indian Institute of Science (IISc) announced its collaboration with CELLINK, a Sweden-based bioprinting solutions company, to provide two to three bioprinters to the Centre of Excellence (CoE), each of which uses a different printing technology at its own cost. Additionally, in December 2022, CELLINK and IISc jointly established Bengaluru's pioneering 3D Bioprinting Centre of Excellence in India. Such innovations, collaborations, and expansion in 3D bioprinting are projected to positively impact the 3D bioprinting market outlook over the forecasted period.

Growing Product Application in Cancer Research

3D bioprinting is widely used in the creation of realistic tumor models that closely mimic the complexity and microenvironment of actual human tumors. These bioprinted models enable researchers to study cancer progression, metastasis, and tumor-stroma interactions in a controlled setting. Moreover, the escalating cases of cancer across the globe are further offering lucrative growth opportunities to the overall market. For instance, the International Agency for Research on Cancer (IARC) estimated that, in the year 2020, there were about 19.29 million cancer cases. These cases are projected to increase to 24.58 million cases by 2030. Additionally, according to GLOBOCAN, in 2020, there were approximately 2,281,658 new cancer cases diagnosed and 612,390 deaths due to cancer alone in the United States. In addition to this, lung cancer and breast cancer are two of the most common cancers found among individuals. The Canadian Cancer Society (CCS) stated that in 2020, nearly 29,800 Canadians were diagnosed with lung cancer, which accounted for 13% of all new cancer cases. About 21,200 Canadians were expected to die from lung cancer, which represented 25% of all cancer deaths in 2020. Such a substantial growth in cancer cases is augmenting the demand for 3D bioprinting technologies that help identify effective treatments, understand drug resistance mechanisms, and personalize cancer therapies.

Global 3D Bioprinting Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global 3D bioprinting market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on component, application, and end user.

Component Insights:

  • 3D Bioprinters
    • Syringe/Extrusion Bioprinting
    • Inkjet Bioprinting
    • Magnetic Levitation Bioprinting
    • Laser-assisted Bioprinting
    • Others
  • Scaffolds
  • Biomaterials
    • Living Cells
    • Hydrogels
    • Extracellular Matrices
    • Others

3D bioprinters (syringe/extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others) represented the largest segment

The 3D bioprinting market research report has provided a detailed breakup and analysis of the 3D bioprinting market based on the component. This includes 3D bioprinters (syringe/extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others), scaffolds, and biomaterials (living cells, hydrogels, extracellular matrices, and others). According to the report, 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others) represented the largest segment.

The bolstering demand for 3D bioprinters can be attributed to the increasing utilization of syringe or extrusion-based bioprinting technology in printing various biological compounds or devices. They are widely used in fabricating tissue scaffolds for regenerative medicine, developing organ models for transplant research, and creating realistic tissue models for drug testing and cancer research. Moreover, 3D bioprinters have the ability to produce complex, customized biological structures, improve the accuracy of drug testing, and reduce the need for animal testing. As a result, they are widely used in the fields of tissue engineering, personalized medicine, pharmaceutical development, and medical research.

Application Insights:

  • Research
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical
    • Skin
    • Bone and Cartilage
    • Blood Vessels
    • Others

Research (drug research, regenerative medicine, and 3D cell culture) accounted for the largest market share

A detailed breakup and analysis of the 3D bioprinting market based on the application has also been provided in the report. This includes research (drug research, regenerative medicine, and 3D cell culture) and clinical (skin, bone and cartilage, blood vessels, and others). According to the report, research (drug research, regenerative medicine, and 3D cell culture) accounted for the largest market share.

The growth of this segment can be attributed to the widespread utilization of 3D printing technology among researchers to study the effects of different diseases and their progression and possible treatments. Moreover, it reduces the need to use lab animals for medical tests and dangerous trials on humans. Additionally, the 3D bioprinting market forecast by IMARC indicates that the increasing drug development and drug trial activities are bolstering the application of 3D bioprinting in research. For instance, with the COVID-19 pandemic behind, the US Food and Drug Administration (FDA) approved 55 new drugs in 2023, a figure consistent with the number authorized in the last five years (53 per year on average). Thus, 2023 marks the second-best yearly FDA harvest after 2018 (59 approvals) in all the series. Such a significant growth in drug trials and approval is creating a positive outlook for the overall market.

End User Insights:

  • Hospitals
  • Research Organization and Academic Institutes
  • Biopharmaceuticals Companies

Biopharmaceuticals companies accounted for the largest market share

A detailed breakup and analysis of the 3D bioprinting market based on the end user has also been provided in the report. This includes hospitals, research organization and academic institutes, and biopharmaceuticals companies. According to the report, biopharmaceuticals companies accounted for the largest market share.

The 3D bioprinting market statistics by IMARC indicate that the increasing number of target therapies is primarily driving the growth of this segment. In addition to this, the rising collaborations and mergers and acquisition activities among biopharmaceutical companies to develop 3D bioprinting are positively influencing the market. For instance, in June 2022, REGEMAT 3D, a company at the forefront of personalized bio fabrication solutions, announced a partnership with Humabiologics, a company providing human-derived biomaterials for regenerative medicine, in response to the growing demand and to serve a broader life sciences customer base of the industry partners and academic institutions in the European bioprinting and drug testing market.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America (the United States and Canada) was the largest market for 3D bioprinting

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for 3D bioprinting.

Some of the factors driving the North American 3D bioprinting market included the growing prevalence of various chronic diseases, the presence of key players, and increasing private and government investments. Additionally, new product launches by the key market players in the region, along with the easy allocation of funds to conduct R&D activities, are further creating a positive outlook for the overall market. For instance, in 2022, scientists from Florida Atlantic University and the University of Virginia created a robotic model of the human spine to assist surgeons in anticipating the outcomes of interventions before surgery. Thus, the increasing demand for 3D bioprinting for healthcare physicians is expected to boost the market over the forecast period. Additionally, the rising investments by the regional government authorities in the healthcare sector are projected to propel the 3D bioprinting market share in the coming years.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global 3D bioprinting market. Some of the companies covered in the report include:

  • 3D Systems Inc.
  • Aspect Biosystems Ltd.
  • Cellink
  • Cyfuse Biomedical K.K.
  • EnvisionTEC GmbH (Desktop Metal Inc.)
  • GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
  • Materialise
  • Organovo Holdings Inc.
  • Poietis
  • RegenHU
  • Stratasys Ltd.

(Please note that this only represents a partial list of companies, and the complete list has been provided in the report.)

Global 3D Bioprinting Market News:

  • June 2024: Advanced tissue mimetic technologies company Ronawk partnered with B9Creations to develop and mass-produce 3D bio-printed hydrogels leveraging Ronawk's Bio-Blocks.
  • February 2024: Nanavati Max Super Specialty Hospital in Mumbai, India, launched a medical 3D printing laboratory to facilitate high-precision surgeries. The facility is closely integrated with oncology to enable state-of-the-art surgeries that need to be performed carefully and accurately in oncologic, reconstructive orthopedic, and specialized dentistry surgeries. The 3D printing laboratory features two 3D printers capable of producing bone models for a better understanding of intricate anatomy or pathology.

Key Questions Answered in This Report

  • 1. What was the size of the global 3D bioprinting market in 2023?
  • 2. What is the expected growth rate of the global 3D bioprinting market during 2024-2032?
  • 3. What are the key factors driving the global 3D bioprinting market?
  • 4. What has been the impact of COVID-19 on the global 3D bioprinting market?
  • 5. What is the breakup of the global 3D bioprinting market based on the component?
  • 6. What is the breakup of the global 3D bioprinting market based on the application?
  • 7. What is the breakup of the global 3D bioprinting market based on the end user?
  • 8. What are the key regions in the global 3D bioprinting market?
  • 9. Who are the key players/companies in the global 3D bioprinting market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global 3D Bioprinting Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 3D Bioprinters
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Syringe/Extrusion Bioprinting
      • 6.1.2.2 Inkjet Bioprinting
      • 6.1.2.3 Magnetic Levitation Bioprinting
      • 6.1.2.4 Laser-assisted Bioprinting
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Scaffolds
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biomaterials
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Living Cells
      • 6.3.2.2 Hydrogels
      • 6.3.2.3 Extracellular Matrices
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Research
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Drug Research
      • 7.1.2.2 Regenerative Medicine
      • 7.1.2.3 3D Cell Culture
    • 7.1.3 Market Forecast
  • 7.2 Clinical
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Skin
      • 7.2.2.2 Bone and Cartilage
      • 7.2.2.3 Blood Vessels
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Organization and Academic Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Biopharmaceuticals Companies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3D Systems Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Aspect Biosystems Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cellink
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Cyfuse Biomedical K.K.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 EnvisionTEC GmbH (Desktop Metal Inc.)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Materialise
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Organovo Holdings Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Poietis
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 RegenHU
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stratasys Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: 3D Bioprinting Market: Major Drivers and Challenges
  • Figure 2: Global: 3D Bioprinting Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: 3D Bioprinting Market: Breakup by Component (in %), 2023
  • Figure 5: Global: 3D Bioprinting Market: Breakup by Application (in %), 2023
  • Figure 6: Global: 3D Bioprinting Market: Breakup by End User (in %), 2023
  • Figure 7: Global: 3D Bioprinting Market: Breakup by Region (in %), 2023
  • Figure 8: Global: 3D Bioprinting (3D Bioprinters) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: 3D Bioprinting (3D Bioprinters) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: 3D Bioprinting (Scaffolds) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: 3D Bioprinting (Scaffolds) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: 3D Bioprinting (Biomaterials) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: 3D Bioprinting (Biomaterials) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: 3D Bioprinting (Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: 3D Bioprinting (Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: 3D Bioprinting (Clinical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: 3D Bioprinting (Clinical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: 3D Bioprinting (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: 3D Bioprinting (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: United States: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: United States: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Canada: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Canada: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Asia-Pacific: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Asia-Pacific: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: China: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: China: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Japan: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Japan: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: India: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: India: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: South Korea: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: South Korea: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Australia: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Australia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Indonesia: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Indonesia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Europe: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Europe: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Germany: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Germany: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: France: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: France: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United Kingdom: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United Kingdom: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Italy: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Italy: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Spain: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Spain: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Russia: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Russia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Latin America: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Latin America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Brazil: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Brazil: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Mexico: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Mexico: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Middle East and Africa: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Middle East and Africa: 3D Bioprinting Market: Breakup by Country (in %), 2023
  • Figure 72: Middle East and Africa: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Global: 3D Bioprinting Industry: SWOT Analysis
  • Figure 74: Global: 3D Bioprinting Industry: Value Chain Analysis
  • Figure 75: Global: 3D Bioprinting Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: 3D Bioprinting Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: 3D Bioprinting Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: 3D Bioprinting Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: 3D Bioprinting Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: 3D Bioprinting Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: 3D Bioprinting Market: Competitive Structure
  • Table 7: Global: 3D Bioprinting Market: Key Players